Rainbow Children’s Medicare: Q1 FY27 Revenue Grows 33%, Expands to Mumbai

Rainbow Children’s Medicare Limited announced a robust performance for the first quarter of FY27, with revenue increasing 33% year-on-year to INR 4,700 million. The company also highlighted its strategic expansion into Mumbai with plans for a 100-bed hospital and strengthened its presence in Andhra Pradesh through acquisitions. EBITDA grew 29.9%, reflecting operational discipline.

Rainbow Children’s Medicare Reports Strong Q1 FY27 Results

Rainbow Children’s Medicare Limited (RCML), a leading pediatric and perinatal healthcare network, has announced its financial results for the quarter ended June 30, 2026. The company delivered a strong performance, with revenue growing approximately 33% year-on-year (YoY) to INR 4,700 million. This growth was driven by a strong performance across both mature and new hospitals.

Key Financial Highlights

The company reported a healthy EBITDA margin of approximately 28.6%. EBITDA for the quarter stood at INR 1,346 million, an increase of 29.9% compared to Q1 FY26. Profit After Tax (PAT) also saw a significant rise, reaching INR 625 million, up 16.2% YoY.

Strategic Expansion and Growth Initiatives

Rainbow Children’s Medicare is set to expand its geographical footprint by entering the Mumbai market with a planned 100-bed brownfield hospital, expected to commence operations in Q1 FY28. This marks a strategic milestone in entering the Western India market. Additionally, the company is strengthening its presence in Andhra Pradesh by acquiring a 70-bed children’s hospital in Nellore and a new 50-bed hospital in Guntur.

The company is also accelerating its digital transformation journey and investing in technology-led initiatives to enhance patient experience and streamline operations. Looking ahead, Rainbow Children’s Medicare aims to strengthen operational excellence, improve occupancy, and drive efficiencies across its network.

Operational Performance

Operational highlights for Q1 FY27 include a 26% increase in capacity beds to 2,435 and a 22% increase in operational beds to 1,862. Inpatient discharges grew by 28%, and outpatient consultations rose by 25%. Deliveries saw a 23% increase.

Source: BSE

Previous Article

Privi Speciality Chemicals: Q1 FY27 Investor Presentation Outlines Strong Growth

Next Article

Ganesha Ecosphere: Corrects Financial Results for March 2026 Quarter